Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.94 USD | +3.42% | +7.57% | +12.25% |
Sales 2024 * | 19.11M 26.12M | Sales 2025 * | 97.66M 133M | Capitalization | 2.99B 4.08B |
---|---|---|---|---|---|
Net income 2024 * | -165M -226M | Net income 2025 * | -126M -172M | EV / Sales 2024 * | 124 x |
Net cash position 2024 * | 618M 845M | Net cash position 2025 * | 514M 702M | EV / Sales 2025 * | 25.3 x |
P/E ratio 2024 * |
-18
x | P/E ratio 2025 * |
-23.5
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on IDEAYA Biosciences, Inc.
1 day | +3.42% | ||
1 week | +7.57% | ||
Current month | -8.98% | ||
1 month | -6.05% | ||
3 months | -5.33% | ||
6 months | +47.60% | ||
Current year | +12.25% |
Managers | Title | Age | Since |
---|---|---|---|
Yujiro Hata
FOU | Founder | 49 | 15-05-31 |
Andres Briseno
DFI | Director of Finance/CFO | 38 | 16-07-31 |
Michael White
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Terry Rosen
BRD | Director/Board Member | 64 | 16-05-05 |
Wendy Yarno
BRD | Director/Board Member | 68 | 19-12-16 |
Catherine Mackey
BRD | Director/Board Member | 68 | 22-04-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.24% | 2 M€ | -.--% | ||
0.09% | 7 M€ | -.--% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 39.94 | +3.42% | 619,378 |
24-04-25 | 38.62 | -3.09% | 734,655 |
24-04-24 | 39.85 | +2.13% | 1,369,718 |
24-04-23 | 39.02 | +3.80% | 486,221 |
24-04-22 | 37.59 | +1.24% | 784,204 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.25% | 2.99B | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- IDYA Stock